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Abstract.  We have generated transgenic mice contain- 
ing additional copies of the murine NF-L gene in or- 
der to examine the consequences of neurofilament-L 
overexpression on axonal morphology. Founder mice 
were constructed to carry a  transgene in which the 
presumptive 5' promoter sequences of NF-L were 
replaced with the strong murine sarcoma virus long 
terminal repeat promoter.  The transgenes were ex- 
pressed prominently in several tissues, including skele- 
tal muscle and kidney where NF-L accumulated to 
,,02%  of cell protein.  This was not accompanied by an 
overt phenotype, except that expression in lens led to 
cataract formation. In the brains of these animals, 
transgene RNA levels exceeded the endogenous NF-L 
RNAs by up to 20-fold, although no additional protein 
accumulated, indicating posttranscriptional regulation 
of NF-L expression.  However, in peripheral  neurons 
transgene RNA was approximately fourfold higher 
than endogenous NF-L mRNAs, and a corresponding 
increase in NF-L subunits was found in axons arising 
from these neurons.  Myelinated nerve fibers of trans- 
genic animals contained increased numbers of NFs, 
assembled predominantly of NF-L. This was reflected 
in an increase in the density of axonal NFs; axonal 
caliber was not affected. 
I 
NTERMEDIATE  filaments  (IFs) 1  are  10-nm  filaments 
which, together with microtubules and microfilaments, 
form the cytoskeleton of eukaryotic cells. However, un- 
like microtubules and microfilaments whose subunits are 
well conserved in sequence, IFs from different tissues are as- 
sembled from a more divergent subunit composition. This 
heterogeneity has been shown by biochemical, immunologi- 
cal, and molecular characterization to be due principally to 
differences in the "head" and "tail" domains of the subunit 
polypeptides which otherwise all contain a central, structur- 
ally conserved, a-helical coiled-coil domain of ~ 310 resi- 
dues (Geisler and Weber, 1986; Franke, 1987; Steinert and 
Roop, 1988). On the basis of sequence differences and on the 
conservation of the intron positions, IFs have been divided 
into five generally accepted classes. Class I and class II are 
composed of the type I (acidic) and type II (basic)  keratins, 
respectively, both of which are expressed in epithelial cells. 
Class  III consists of vimentin expressed  in  mesenchymal 
cells, desmin expressed in muscle cells, glial fibrillary acid 
Mervyn J. Monteiro's present address is Department of Neurology and the 
Medical  Biotechnology Center,  The  University of Maryland School of 
Medicine, Baltimore, Maryland 21201. 
1. Abbreviations used in this paper:  DRG, dorsal root ganglia; IF,  inter- 
mediate filament; LTR, long terminal repeat; MSV, murine sarcoma virus; 
NF,  neurofilament. 
protein expressed in glial cells, and peripherin expressed in 
a subset of neurons of the peripheral nervous system. Class 
IV comprises the major neurofilament (NF) proteins that are 
probably expressed in all neuronal cells. Class V comprises 
the nuclear lamins. The newly discovered IF subunit nestin, 
found in neuroepithelial stem cells, has been proposed to 
represent a separate sixth IF class (Lendahl et al.,  1990). 
In  mammals,  NFs  are  composed  primarily  of  three 
subunits, NF-L (68 kD), NF-M (160 kD), and NF-H (200 
kD) (Hoffman and Lasek, 1975). Each carries a 310-amino 
acid c~-helical rod domain following an •100-residue  head 
domain, and differences in  size are  primarily due to the 
length of the carboxy-terminal tail sequences  (Lewis and 
Cowan, 1986; Levy et al., 1987; Myers et al.,  1987; Julien 
et al., 1988; Lees et al., 1988). The disposition of the three 
NF proteins in the native polymer is not known; however, 
since all three subunits contain the rod domain, almost cer- 
tainly each is an integral filament subunit. The role of head 
and tail domains is less clear but immunocytochemical and 
in vitro reassembly experiments suggest that the tail domains 
of NF-M and NF-H are mostly involved in the formation of 
NF cross-bridges (Geisler and Weber,  1981; Sharp et al., 
1982;  Geisler et al.,  1983;  Julien and Mushynski,  1983; 
Minami and Sakai,  1985;  Hirokawa et al.,  1984;  Hisanaga 
and Hirokawa,  1988). 
A  convincing functional role  for any IF has  yet to be 
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Figure  1.  Schematic  drawings  of the 
mouse NF-L gene  and  the  two  NF-L 
transgene  constructs.  (A)  Restriction 
map and principal  features  of the 7-kb 
Hind III fragment containing the mouse 
NF-L gene.  (B)  Schematic  drawing of 
pNF-L(Bam).  This gene was constructed 
by inserting  a 18-bp sequence,  contain- 
ing Bam HI and Xba I restriction  sites, 
between  the Ava I  and Mst II sites  of 
pNF-L (5 bases were deleted in this pro- 
cess leaving a  net insertion  of 13 bp). 
(C) Schematic drawing of pMSV-NF-L. 
This gene was constructed by replacing 
the 5' 1.7-kb Hind III-Bam HI fragment 
of pNF-L(Bam)  with  the  0.6-kb  Hind 
III-Bgl  I  fragment  that  contains  the 
MSV promoter segment. 
proven, although the keratin and lamin networks are almost 
certainly required  for structural  integrity of the epidermis 
and nuclear lamina, respectively. For NFs, a functional role 
was first suggested on the basis of the close correlation be- 
tween  the  number  of axonal  NFs  and  the  cross-sectional 
areas of large myelinated nerve fibers (Friede and Samoraj- 
ski,  1970; Weiss and Mayr, 1971; Berthold,  1978). More di- 
rect evidence for a role of NFs in the control of axonal caliber 
was provided by the observation that reductions in NF gene 
expression after axotomy correlate with somatofugal axonal 
atrophy (Hoffman et al.,  1987).  This axonal atrophy, which 
is  associated  with reductions in both the amount of pulse- 
labeled NF protein undergoing axonal transport in the prox- 
imal stumps of transected nerve fibers and axonal NF con- 
tent, begins proximally near the cell body (soma) and spreads 
somatofugally along the nerve fiber at a rate equal to the ve- 
locity of NF transport along the axon (Hoffrnan et al.,  1984; 
1985). Additional evidence for the role of NFs in the control 
of caliber comes from recent studies  which  show that the 
radial growth of myelinated nerve fibers, which occurs dur- 
ing postnatal  development,  correlates  temporally  with  the 
induction of NF gene expression in developing sensory neu- 
rons (Muma, N. A., and P. N. Hoffman, unpublished obser- 
vations). 
NF-L is the most abundant NF subunit and in vitro experi- 
ments have shown it to be capable of assembly without the 
other subunits (Geisler and Weber, 1981; Liem and Hutchin- 
son, 1982). We previously demonstrated that forced expres- 
sion of NF-L in fibroblasts resulted  in the assembly of the 
protein into filaments and was not detrimental to the growth 
of fibroblasts (Monteiro and Cleveland,  1989).  However, it 
was not known if similar high levels of inappropriate expres- 
sion of an IF would affect embryogenesis or development. To 
begin to address such questions,  including the role of each 
NF subunit in neuronal function, we have generated trans- 
genic mice expressing high levels of NF-L in both neuronal 
and nonneuronal cell types. The resultant increased expres- 
sion and assembly of NF-L in neurons allowed us a first test 
of the hypothesis that NF expression  is an intrinsic  deter- 
minant of axonal caliber.  We show that increased NF-L ex- 
pression alone is in fact not sufficient to affect axonal caliber; 
rather, it generates disorganization of the NF array in axons. 
Materials and Methods 
Molecular Cloning of the Mouse 
pNF-L Gene: Construction of  pNF-L(Bam) and 
pMSV-NF-L Transgenes 
As described previously, the complete NF-L gene of mouse was isolated as 
a 7-kb Hind III fragment, and subcloned into pUC9 to yield pNF-L (Mon- 
teiro and Cleveland, 1989). For transgenic animals, pNF-L was manipu- 
lated to produce  two additional clones, pNF-L(Bam)  and pMSV-NF-L  (Fig. 
1). pNF-L(Bam) contains the entire NF-L coding sequences including 1,7 
kb of sequences 5' to the ATG start codon and 1.7 kb of 3' terminal noncod- 
The Journal of Cell Biology, Volume 111, 1990  1544 lqgure 2. Identification of pNF-L(Bam) 
transgenic mice and analysis of its ex- 
pression in various mouse tissues. (A) 
A blot of mouse tail DNA (10 #g) was 
(digested with both Barn HI and Eco 
RI) probed with a  radiolabeled probe 
corresponding to the 4.2-kb Bam HI- 
Eco RI fragment of pNF-L(Bam). (lane 
1)  Transgenic  mouse  ceNF-9  DNA; 
(lane  2)  transgenic  mouse  qNF-16 
DNA;  (lane  C)  nontransgenic  litter- 
mate.  The endogenous  NF-L  gene is 
contained on a 9-kb fragment whereas 
the transgene is contained on a 4.2-kb 
fragment.  Both transgenic mice  con- 
tained  approximately  one  to  two  in- 
tegrated  transgene  copies.  (B)  RNA 
expression  of pNF-L(Bam)  in  trans- 
genic  mouse  tissues.  RNA  was  iso- 
lated from various tissues of a  trans- 
genic F1 progeny of line cYNF-9.  10-#g 
aliquots were analyzed for NF-L RNAs 
using  S1  nuclease  protection  of  an 
end-labeled  probe  corresponding  to 
the Hind III-Ava I  fragment of pNF- 
L(Bam). RNAs from the transgene are 
expected to yield a  183-base protected 
fragment, whereas a 93-base fragment 
is  expected  from  endogenous  NF-L 
mRNAs. Two protected fragments seen 
in all lanes ('~114 and  125 bases) are 
contaminants in  the  probe  and  were 
seen even  when no RNA  was  added 
(left lane).  The position of migration 
of pBR322-digested Hpa II DNA frag- 
ments of known size are marked at the 
right. 
ing sequences.  This clone differs from the authentic gene by insertion of an 
18-base linker sequence at the abutting Ava I-Mst II sites in the 5' untrans- 
lated region, resulting in the loss of 5 NF-L nucleotides  but a net gain of 
13 nucleotides.  Using S1 nuclease protection methods, transcripts derived 
from pNF-L(Bam) can be distinguished from authentic NF-L RNAs by the 
presence of the linker sequence (Monteiro and Cleveland, 1989).  pMSV- 
NF-L was constructed by replacing the Hind III-Bam HI fragment of pNF- 
L(Bam) with a 0.6-kb Hind III-Bgl II fragment containing the murine sar- 
coma virus (MSV) long terminal repeat (LTR) (Fig.  1 C; see also Monteiro 
and Cleveland,  1989). 
Production of Transgenic Mice 
Embryos were  recovered  from the oviducts  of superovulated  B6AFIJ fe- 
males ",12 h after fertilization.  The female pronucleus of one-cell embryos 
was injected with '~300 copies of DNA fragments containing either the 7-kb 
Hind HI fragment of the pNF-L(Bam) gene construct (Fig.  1 B) or with 5.9- 
kb Hind III fragment of pMSV-NF-L (Fig.  1 C). The DNA fragments were 
gel purified from vector sequences using DEAB paper (Dretzen et al., 
1981). After incubation  at 37°C for 18 h in Whitten's medium, the surviving 
two-cell  embryos were transferred to the oviducts of pseudopregnant CD1 
females.  Mice born from these mothers were analyzed for the presence of 
the transgenes as described below. 
Southern Blotting of Mouse Tail DNA 
Transgenic mice were identified by screening DNA isolated from mouse tail 
for the presence of the injected DNA fragments.  3 wk after birth a portion 
of the mouse tail was excised with a razor blade, and the tissue dispersed 
with a polytron homogenizer into 10 ml of 10 mM Tris-HC1, pH 7.5, 100 
mM NaC1, 1 mM sodium EDTA. The samples were incubated at 37"C for 
1 h after addition of Sarkosyl  to 1% (wt/vol),  pronase to 200 ttg/ml, and 
RNase A to 100 #g/ml. The DNA was extracted once with phenol/chloro- 
form (1:1), once with ether, then adjusted  to 0.3 M with potassium acetate 
and precipitated at -20oc with 2 vol ethanol. The DNA precipitate was 
collected by centrifugation,  resuspended in 10 mM Tris-HCl, 1 mM sodium 
EDTA, and a 10-#g aliquot was cleaved with restriction enzymes (Eco RI 
and Barn HI for analysis of the pNF-L[Bam] transgene and with Sac I for 
the analysis of the pMSV-NF-L transgene), separated by agarose gel elec- 
trophoresis, and transferred onto nitrocellulose paper (Southern,  1975). 
The nitrocellulose was baked at 80°C for 1 h; prehybridized at 42°C in 50% 
formamide,  5x SSC (lx SSC is 0.15 M NaC1, 0.015 M sodium citrate, pH 
7.0), 50 mM Tris-HCl,  pH 7.5, 0.5%  (wt/vol) SDS,  1 mM sodium EDTA, 
5×  Denhardt's solution (Denhardt,  1966),  and  100 #g/ml of sonicated, 
denatured salmon sperm DNA; and then hybridized for 48 h with 1 x  106 
cpm/ml of labeled probe prepared by random primer extension using radio- 
active t~-32p-dATP and AMV reverse  transcriptase. For detection of the 
pNF-L(Bam) transgene, the probe was the 4.2-kb Barn HI-Eco RI fragment 
of pNF-L(Bam) (Fig.  1 B). 
SDS-PAGE and Immunoblot Detection of NF-L in 
Tissue Samples 
Mouse tissues were lysed in 0.5 % (wt/vol) SDS, 50 mM Tris-HCl, pH 6.8, 
8 M urea, then boiled in Laemmli loading buffer (Laemmli, 1970) contain- 
ing 2 % fl-mereaptoethanol, and the proteins were separated by electropho- 
resis on 6 or 8.5%  polyacrylamide gels (Laemmli,  1970).  Proteins were 
transferred onto nitrocellulose filters (type BA83; Schleicher and Schuell, 
Inc., Keene, NH) and immunoblotted as described by Lopata and Cleveland 
(1987).  NF-L protein  was detected  by autoradiography  by incubating  the 
filters  first with the mouse monoclonal anti-NF-68 antibody (Boehringer 
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genic mice express high levels 
of NF-L in many different tis- 
sues.  (A  and  B)  Coomassie 
blue-stained gels of tissue ex- 
tracts  (40 /~g of protein ana- 
lyzed per lane) from different 
tissues of a control and a trans- 
genic mouse (MSV-NF-L-72). 
The tissue  samples  analyzed 
were (B) brain, (L) liver, (K) 
kidney, (H) heart, (S) spleen, 
and  (M)  muscle.  The  gels 
were  calibrated  using  pro- 
tein molecular mass  markers 
(shown  in  kD).  The  arrow 
marks the position of a novel 
protein found  in kidney and 
muscle of transgenic animals. 
(C and D) Immunoblot  of par- 
allel  gels  using  an  NF-L- 
specific  antibody.  (E and F) 
S1  nuclease protection analy- 
ses of the accumulated  NF-L 
RNAs in different tissues of a 
transgenic mouse  (MSV-NF- 
L-72).  RNA  was  isolated 
from  the  tissues  shown  and 
10-/~g aliquots were analyzed 
for NF-L RNAs using the Ava 
I-Ava I fragment of the wild- 
type NF-L  gene (end-labeled 
with  32p) as  the  probe.  SI- 
resistant products at 215 bases 
map to the start of transcrip- 
tion of the endogenous NF-L 
and those at position 145-158 
b report transgene NF-L RNAs. 
(E) RNA from control mouse; 
(F) RNA from MSV-NF-L-72 
transgenic  mouse.  Markers 
(shown  in nucleotides)  were 
Hpa  II  DNA  fragments  of 
pBR322. Figure 4. Assembly of NF-L in primary cul- 
tures  of transgenic fibroblasts.  Primary fi- 
broblasts from mouse embryos of line MSV- 
NF-L-58 were stained in A for NF-L using 
a commercially available  monoclonal anti- 
body to rnurine NF-L and a secondary anti- 
body coupled to fluorescein. (B) Vimentin 
filaments  were  localized  simultaneously 
using  a  rabbit  polyclonal  antibody  to vi- 
mentin and a rhodamine-linked anti-rabbit 
antibody.  Bar,  20 t~m. 
Marmheim Diagnostics, Inc., Houston, TX) followed by 125I-labeled sheep 
anti-mouse antibody (Amersham Corp., Arlington Heights, IL). 
RNA Isolation and S1 Nuclease Protection of  mRNA 
NF-L expression in mouse tissues was examined by S1 nuclease protection 
of mRNA. Total  RNA was isolated from mouse tissue by the guanidinium 
isothiocyanate/cesium chloride method (Chirgwin et al., 1979).  To analyze 
for accumulation of the pNF-LfBam) transgene RNAs, the  1.9-kb  Hind 
[lI-Ava I  fragment of pNF-L(Bam) (Fig.  1 B)  was gel purified,  5' end- 
labeled with -r-32P-dATP using T4 polynucleotide kinase and hybridized to 
5 or 10 #g of total RNA for 18 h at 52°C. Analysis for expression of the 
pMSV-NF-L transgene was performed with 5' end-labeled probes from the 
340-bp Ava I-Ava I of pMSV-NF-L or the 1-kb Bss HII fragment of pNF-L. 
RNA/DNA hybrids were precipitated with ethanol and treated for  1 h  at 
room temperature with 100 U of S1  nuclease in 100 t~l of 0.25 M  NaCI, 
30 mM sodium acetate, 5  mM  ZnCI2,  and 7.5  /~g sonicated, denatured 
salmon sperm DNA. The Sl-resistant radioactive products were separated 
by  electrophoresis through  a  6%  polyacrylamide,  8  M  urea  gel  and 
identified by autoradiography. The size of the protected fragments was de- 
termined by comparison with the mobilities of 32P-labeled  fragments of 
Hpa II--digested pBR322. 
Immunofluorescence Microscopy of 
Transgenic Fibroblasts 
Cultures of fibroblastic cells were prepared from adult (3-mo-old) trans- 
genie or control mice by mincing sections of thigh muscle with a  razor 
blade, followed by brief trypsinization. The resultant cell suspension was 
plated onto plastic culture dishes and grown for 2 wk in DME plus 10% 
FCS. Media were changed every 3 d. This yielded a population of  remaining 
cells that was enriched in fibroblasts. 
For irnmunoftuorescence, cells were trypsinized and plated onto glass 
coverslips. For visualization of NF and vimentin arrays, cells were washed 
for 30 s at room temperature in 4 M glycerol, 100 mM Pipes, pH 6.9, and 
1 mM EGTA, and then extracted for 30 s in the same solution containing 
0.5% Triton X-100. The first wash was repeated and the samples were fixed 
in  -20°C methanol for 5 min. The samples were rehydrated in PBS and 
incubated with an antibody solution (containing PBS supplemented with 1% 
nonfat dry milk) for 1 h at room temperature. After a similar incubation 
with a solution containing secondary antibodies, the coverslips were washed 
in PBS and mounted on glass slides using Aqua-mount (Lerner Laborato- 
ries, New Haven, CT). Cells were examined on an Olympus BH-2 micro- 
scope using epifluorescence  optics and photographed on TMAX film (East- 
man Kodak Co., Rochester, NY).  Primary antibodies used were a mouse 
mAb to NF-L (Boehringer Mannheim Biochemicals, Indianapolis, IN) and 
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Affinity-purified fluorescein- and rhodamine-conjngated antibodies specific 
for each of the primary antibodies were obtained from ICN Immunobiolog- 
icals. 
Pulse Labeling of Proteins in Isolated Dorsal 
Root Ganglia 
The right and left L4 and L5 dorsal root ganglia (DRG) were isolated from 
anesthetized mice (chloral hydrate 400 mg/kg, i.p.) and immediately placed 
in warm (37"C) DME. Newly synthesized proteins were labeled by incubat- 
ing the DR(] for 15 rain at 37°C in 150 ~1 of methionine-free DME sup- 
plemented with 250 t~Ci of L-[35Slmethionine. The DRG were then washed 
in medium lacking the radioactive label and frozen at -700C.  To analyze 
the proteins labeled, the DRG were lysed by homogenization in 0.5 % SDS 
(wt/vol), 50 mM Tris, pH 6.8. Protein concentration was determined by the 
bicinchonic acid method (Smith et al.,  1985) and the amount of radiolabel 
incorporated determined by TCA precipitation. Either equal TCA-insoluble 
counts or equal protein fractions were analyzed by SDS-PAGE from trans- 
genic mice and n0ntransgenic linermates to determine whether there was 
increased NF-L synthesis in the transgenic samples. 
In Situ Hybridization 
In situ hybridization was performed following the method of Lewis and Cowan 
(1985a). Lumbar DRG were removed from anesthetized mice, fixed by im- 
mersion in 4% paraformaldehyde fixative, embedded in paraffin, and sec- 
tioned (8 #m). Sections were acetylated with acetic anhydride before hybrid- 
ization with 3~S-labeled NF-L cDNAs (Lewis and Cowan,  1985b).  Slides 
were washed under low stringency conditions (150 mM NaC1,  15 mM Na- 
citrate, 50°C) dipped in Kodak NTB3 emulsion, and exposed for 5-10 d. 
Morphological Analyses of  Axonal Cross-sectional 
Area and Axonal NF Content 
The sciatic nerves of anesthetized mice were exposed and fixed in situ with 
5 % glutaraldehyde.  Nerve segments were excised, fixed by immersion in 
fixative for an additional 24 h, postfixed in osmium, dehydrated, and em- 
bedded in Epon. For analyses of axonal caliber, 1-/~m thick light microscope 
sections were stained with toluidine blue. Axonal cross-sectional areas were 
measured in corresponding regions of sciatic nerves from transgenic and 
nontransgenic littermate animals using a Bioquant computer-based system 
(R. M. Biometrics, Inc., Nashville, TN). For electron microscopic analyses 
of axonal NF content, representative areas of axoplasm from age-matched 
transgenic and control nerve fibers were photographed at a magnification 
of 25,000. Photographs were printed at a final magnification of 62,500, and 
NF  cross  sections  were  counted  by  two  of the  authors  (Hoffman  and 
Cleveland). 
Immunohistochemistry 
DRG and kidney, fixed by intracardiac perfusion of anesthetized mice with 
4% paraformaldehyde, were embedded in parraffin, and sectioned (8 #m). 
Tissue sections were deparaffinized,  incubated for  1 h  in 5%  nonfat de- 
hydrated milk, and then incubated for 24 h in a rabbit polyclonal anti-NF-L 
antibody (kindly provided by Dr. Gerry Shaw,  University of Florida) used 
at a 1:200 dilution in 5% nonfat dehydrated milk. (The commercial mono- 
clonal antibody to NF-L could not be used because it did not recognize NF-L 
in formalin-fixed tissue.) Sections were then washed, incubated for 1 h in 
goat  anti-rabbit antibody  (diluted  1:20),  washed  again,  and  finally  in- 
cubated for 1 h in rabbit peroxidase-antiperoxidase. Development was per- 
formed with 0.05%  diaminobenzidine tetrahydrochloride/0.01%  hydrogen 
peroxidase (5 rain). All washes and solutions were in 0.05 M Tris-buffered 
0.9% saline, pH Z6. All incubations were carried out at room temperature. 
Sections  were  coverslipped,  examined  by  light  microscopy,  and  pho- 
tographed. 
Results 
To produce mice bearing NF-L transgenes that might express 
increased NF-L in axons, we initially chose to inject the 7-kb 
Hind III DNA fragment containing the mouse NF-L gene 
into one-cell mouse embryos. We marked the injected DNA 
with a 13-base insertion within the 5' untranslated region of 
the NF-L gene so that the RNA from this transgene (pNF- 
L[Bam]; Fig.  1 B; see also Monteiro and Cleveland, 1989) 
could be clearly distinguished from that transcribed from the 
maternal and paternal NF-L genes. The encoded transgene 
polypeptide was the authentic, wild-type NF-L subunit. Two 
transgenic founder mice were obtained (crNF-9 and 9NF- 
16) and DNA blotting showed that each contained one to two 
copies of the complete NF-L gene (Fig. 2 A). Using S1 pro- 
tection of RNA isolated from various tissues, transgenic F1 
progeny from each founder were assayed for expression of 
the transgene. By choosing an end-labeled S1 probe that con- 
tained the linker sequence that we had placed in the 5' un- 
translated region of the transgene (the Hind III-Ava I frag- 
ment of pNF-L[Bam]; Fig.  1 B), this probe simultaneously 
reported the RNA levels of the transgene (a  183-base pro- 
tected fragment extending from the site of labeling to the site 
of transcription initiation) and the endogenous NF-L genes 
('093-base fragment extending from the site of labeling to 
the site of  linker insertion). In both founders, transgene RNA 
accumulated only in brain, but not in liver, kidney, heart, 
spleen, or muscle (see Fig. 2 B for cy NF-9). However, nei- 
ther transgene was as highly expressed as the endogenous 
NF-L RNAs, with cyNF-9 RNA accumulation ,020% of the 
endogenous  and  9NF-16  RNA  ,°3%  of the  endogenous. 
Since the transgene encodes a wild-type NF-L protein, we 
could not assay directly for accumulation of protein encoded 
by it; however, immunoblot analysis of total NF-L protein 
in  brain  tissue  was  not detectably different in  transgenic 
animals compared with control littermates (data not shown). 
Production of Transgenic Mice Containing the NF-L 
Gene under the Control of the MSV LTR Promoter 
Previously, we demonstrated in transfection experiments that 
in  cultured  mouse  L  cells  the  NF-L gene was  expressed 
"010-20-fold higher when the NF-L promoter was replaced 
with the  strong  LTR promoter from MSV  (Monteiro and 
Cleveland,  1989).  Thus,  we reasoned that the MSV  LTR 
might also be suitable to increase expression of the NF-L 
transgene in neurons of transgenic mice. While we were also 
concerned that this viral promoter would probably yield ex- 
pression in a wide variety of cell types and that this might 
be detrimental to the survival of the transgenic animals, we 
nevertheless injected mouse embryos with the MSV-NF-L 
gene construct (see Fig.  1 C).  We obtained 13 transgenic 
founder mice (from 48 born) which blot analysis revealed to 
contain from 1 to 300 copies of the MSV-NF-L transgene 
(data  not  shown).  Indeed,  a  simple  assay  for transgenic 
Figure 5. Accumulation of NF-L filaments in transgenic kidney. (A) Light micrograph of a l-#m-thick plastic section of a kidney from 
mouse line MSV-NF-L-58 (stained with toluidine blue). Bar, 20 #m. (B) Nomarski image of  a similar, but unstained section after incubation 
with a polyclonal antibody to NF-L followed by a secondary antibody conjugated to peroxidase. Bar, 20 #m. (C) Higher magnification 
view using electron microscopy. Bar, 5 #m. (D) The area delineated by the rectangle in C was further magnified to reveal a densely packed 
array of filaments. Bar, 0.5 #m. Arrows in A and B denote nearby proximal tubule cells adjacent to others that accumulate high amounts 
of NF-L. P/;, proximal tubule; DE, distal tubule; RBC, red blood cell; N, proximal tubule cell nuclei. 
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from mouse tails revealed the presence of NF-L in all trans- 
genic founders, but not in control mice. The level of NF-L 
expression in tail correlated to a certain degree with copy 
number but was always similar for littermates acquiring the 
same transmitted transgene(s) (data not shown). For exam- 
ple, transgene expression showed some dependence on copy 
number up to •30  copies, but this relationship was not ap- 
parent at higher copy numbers and in some cases other fac- 
tors clearly influenced expression. 
To determine the pattern of transgene expression in differ- 
ent tissues, we used immunoblotting to examine whole cell 
proteins from a series of tissues from control or transgenic 
animals. Fig. 3 displays such an analysis for line MSV-NF-L- 
72. Of the tissues examined in control animals, NF-L was 
restricted to brain as expected; however, in transgenic tis- 
sues, NF-L accumulation was easily detectable by Coomassie 
staining of whole cell extracts of skeletal muscle or kidney. 
Quantitation of these findings by parallel immunoblotting of 
known amounts of partially purified neurofilaments revealed 
NF-L accumulation in these tissues to be ,x,2.5 % of total cell 
protein. In heart,  NF-L contributed 0.5 %  of cell protein, 
while little transgene expression was observable in liver or 
spleen. However, in brain NF-L did not accumulate to a level 
in excess of that in nontransgenic littermates. 
With  one  notable  exception,  a  parallel  comparison  of 
transgene RNA levels in the same tissues revealed a pattern 
similar to that found for accumulated NF-L protein (Fig. 3 
E and F). The striking exception was brain where transgene 
RNAs were more abundant than endogenous NF-L mRNAs 
(Fig. 3 E and F, lanes B). For example, using S1 analysis and 
an end-labeled probe derived from the authentic NF-L gene, 
the endogenous NF-L RNA protected the probe to the start 
site  of transcription  while  transgene  RNAs  (that  diverge 
from the probe at the site of linker insertion) yielded two ma- 
jor protected fragments of 145 and  158 bases  (Fig.  3 F). 
(These major transgene protected fragments are  ~11  and 
,x,24 bases larger than the 134 bases predicted, probably be- 
cause of the failure of $1 to cleave efficiently within either 
of two GC-rich domains that lie just 5' to the point of trans- 
gene RNA/probe DNA sequence divergence.) Inspection of 
the data revealed that transgene RNAs were ~20-fold more 
abundant than NF-L RNAs. Despite this, no increase in ac- 
cumulated NF-L protein was detectable in brain (Fig. 3, C 
and D, lanes B). These results were not unique to the MSV- 
NF-L-72 line; similar relative levels of transgene RNA and 
protein levels were found in analyses of tissues from two 
other founder lines that express the transgene highly (MSV- 
NF-L-58 and MSV-NF-L-103) (not shown). 
The failure of NF-L protein to accumulate in brain may 
have  resulted  from the  transgene  encoding  an  assembly- 
incompetent NF-L subunit which might have been specifical- 
ly susceptible to degradation. To test this, we prepared pri- 
mary cultures of cells enriched in fibroblasts derived from 
transgenic mice and determined the localization of NF-L by 
immunofluorescence light microscopy. An antibody to NF-L 
stained a filamentous array in almost all of the cells from 
transgenic cultures (Fig. 4 A), but none of those derived from 
nontransgenic littermates (not shown).  In fact, double im- 
munofluorescence  revealed  that  NF-L  coassembles  with 
vimentin (Fig. 4 B), the endogenous IF that the fibroblasts 
constitutively express. 
To confirm further that the transgene encoded assembly- 
competent molecules, we used light and electron microscopy 
to analyze the kidneys of MSV-NF-L-58, in which NF-L ac- 
cumulated to 2.5 % of cell protein. Sections obtained from 
transgenic kidneys showed that proximal tubule cells con- 
tained substantial levels of NF-L, which was easily observ- 
able by immunoperoxidase staining with the NF-L antibody 
(Fig. 5 B). No NF-L was observed in distal tubules or the 
surrounding cells-for example, red blood cells (Fig. 5 A), 
or in kidneys from control animals. In fact, in many affected 
tubule cells NF-L accumulation was to such a level that it was 
easily observable as lightly staining domains encompassing 
most of the cell cytoplasm (Fig. 5 A). Higher magnification 
views using electron microscopy more clearly revealed these 
large accumulations of NF-L within tubule cells (Fig. 5 C), 
while even higher magnifications revealed them to be com- 
prised of massive arrays of densely packed filaments 8-10 
nm in diameter (Fig. 5 D). The presence of these accumula- 
tions of filaments had no discernible effect on the longevity 
of the mice (the founder mice are now 2 y old). That such 
massive filament accumulation had no overt phenotypic con- 
sequence is probably because not all proximal tubules were 
affected. For example, morphologically normal tubule cells 
were found to lie adjacent to those most strongly accumulat- 
ing NF-L (see arrows in Fig.  5 A, or the uneven immuno- 
staining within an affected tubule in Fig.  5 B). Why only 
some of the tubule cells are affected is unknown. 
The only obvious phenotypic consequence of expression 
of NF-L outside neurons was the formation of cataracts (Fig. 
6 A). These were especially noticeable in the three lines of 
mice that most highly express the pMSV-NF-L transgene. 
Although we have not followed the levels of NF-L accumu- 
lated during development nor have we carefully monitored 
the onset of cataract formation, cataracts were correlated 
with the presence of NF-L polypeptides in the lens. For ex- 
ample,  Coomassie blue  staining  of proteins  separated by 
electrophoresis revealed a major 68-kD protein unique to 
transgenic  animals  (Fig.  6  B)  and  immunoblotting  con- 
firmed its identity as NF-L (Fig. 6 C). The immunoblot fur- 
ther revealed that the NF-L antibody reacted not only with 
the expected 68-kD NF-L polypeptide but also with a num- 
ber of smaller polypeptides which we presume to be proteol- 
ysis products of the 68-kD polypeptide. Comparison of the 
Coomassie staining  at the NF-L position with that of the 
50-57-kD  region containing vimentin revealed that NF-L 
must be at least fivefold more abundant than vimentin, the 
IF normally expressed in lens. 
In view of NF-L accumulation in nonneuronal tissues, the 
failure of the transgene RNA to elevate NF-L in brain is sur- 
prising, but obviously cannot be the result of an inadvertent 
mutation in the transgene. Rather, it may indicate the pres- 
ence of a posttranscriptional regulatory mechanism that acts 
to  limit  NF-L accumulation  in  some (and  perhaps  most) 
brain cells. 
Expression of NF-L in Peripheral Sensory Neurons of 
Transgenic Mice 
Although we did not detect any increase in accumulated NF-L 
protein in the brains of transgenic mice despite substantially 
increased NF-L mRNAs, we also examined NF-L accumula- 
tion in peripheral neurons. As a tissue rich in neurons, DRG 
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expressing NF-L in lens.  (A) Photographs  of 
eyes of control  and  transgenic  littermates  of 
line  MSV-NF-L-58 at '~6 mo.  (B)  Coomas- 
sie-stained gel and (C) immunoblot of whole 
lens cell extracts of two control and two trans- 
genic MSV-NF-L-58 animals.  NF-L polypep- 
tides were identified in C with the monoclonal 
antibody to NF-L. 
were selected for further analysis. DRG contain the cell bod- 
ies  of  sensory  neurons  as  well  as  axons  ensheathed  by 
Schwann cells, the myelin-forming cells of peripheral nerve. 
Each sensory neuron gives rise to a single axonal stem pro- 
cess, which bifurcates within the ganglion into a central ax- 
onal process that extends to the spinal cord (via the dorsal 
root) and a peripheral axonal process that extends into the 
peripheral nerve (the sciatic nerve, in the case of the L4 and 
L5 DRG analyzed in these studies).  Neuronal protein syn- 
thesis  takes  place exclusively within  the  cell  bodies,  and 
newly  synthesized  cytoskeletal  proteins,  including  NF-L, 
enter the axon where they are translocated towards the axon 
terminals at velocities of several millimeters per day via slow 
axonal transport (Hoffman and Lasek,  1975). 
S1  nuclease analysis of NF-L mRNAs isolated from the 
DRG of line  MSV-NF-L-58 revealed that there was about 
fivefold more transgene RNA than endogenous NF-L RNAs 
(Fig. 7 A, DRG). This was consistent with transgene expres- 
sion in either the neurons or Schwann cells of the DRG, or 
both.  (RNA blotting revealed that the abundance of NF-M 
and NF-H mRNAs was comparable in DRG of transgenic 
and control animals [data not shown].) A similar analysis re- 
vealed the relative absence of either transgene or endogenous 
NF-L RNAs in sciatic nerve (Fig. 7 A, NERVE), which con- 
tains axons and Schwann cells, but not neuron cell bodies. 
(Axons lack ribosomes and mRNAs and cytoplasmic protein 
synthesis in neurons is thus confined to the cell body [Lasek 
et al., 1973].) These results suggested a high level of expres- 
sion of the transgene within the neurons of the DRG. 
To confirm the localization of transgene RNAs in neuronal 
cell bodies in DRG, we used in situ hybridization. For this, 
we used a probe that hybridized both to the transgene and 
to the endogenous NF-L mRNAs. This revealed prominent 
localization of NF-L mRNAs in neuron cell bodies (Fig.  8 
A, large arrows), with little if any hybridization to adjacent 
Schwann cells (Fig. 8 A, small arrows). (Localization unique- 
ly of MSV-NF-L transgene RNAs could not be achieved by 
in  situ  hybridization  since  the  endogenous  and  transgene 
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and  sciatic  nerves  of MSV-NF-L transgenic 
mice. (A) RNA purified from DRG and sciatic 
nerves of MSV transgenic mice (MSV-NF-L- 
58) was analyzed for abundance of  NFoL RNAs 
by SI nuclease protection using the Ava I-Ava 
I  fragment  of pMSV-NF-L (end-labeled  with 
32p) as  the  probe.  Transgene  RNAs  are  re- 
ported  as a  140-base protected  fragment;  the 
endogenous NF-L genes yield 92-96-base pro- 
tected  fragments.  (B)  Isolated  DRG  from 
MSV-transgenic mice synthesize increased lev- 
els of NF-L.  L4 and L5  DRG were isolated 
from two MSV-NF-L-58 transgenic mice and 
from  two  control  nontransgenic  littermates. 
The DRG were pulse labeled for 15 rain with 
[35S]methionine and  the  radioactive  proteins 
separated  by  SDS-PAGE and  analyzed  by 
fluorography.  (C  and  D)  ~tejn, !ysates  of 
sciatic  nerves  (10 /~g in each 1/m~. obtained 
from two control and two transgenic mice were 
separated by electrophoresis.  C displays a gel 
stained with Coomassie blue; D displays an im- 
munoblot analysis of a parallel gel probed with 
a monoclonal antibody to NF-L. 
RNAs differ only in the 5'-most 35 bases and we were unable 
to detect a signal using this 35-base region of the transgene. 
Nevertheless, since the probe reported both endogenous and 
transgene NF-L RNAs localized only to neuronal cells and 
the transgene RNAs are fivefold more abundant in the DRG, 
we infer that the MSV-promoted NF-L transcripts must con- 
tribute at least five-sixths of the  hybridization  signal  seen 
over the cell bodies of the neurons.) Further,  the lack of in 
situ hybridization in regions of DRG enriched in Schwann 
cells and axons but lacking neuron cell bodies (lower region 
of Fig.  8 A) is consistent with the relative absence of NF-L 
RNAs in peripheral nerve (Fig. 7 A, NERVE), whose RNA 
content is contributed primarily by Schwann cells. Previous 
in situ hybridization studies have shown that these Schwann 
cells contain high levels of tubulin mRNAs (Hoffman, P. N., 
and D. W. Cleveland, unpublished observations) and thus the 
lack of hybridization with the NF-L cDNA does not reflect 
limited access of probes to the regions of DRG tissue sec- 
tions enriched in Schwann cells. 
That transgene NF-L expression was absent in the Schwann 
cells  and  largely  confined  to  the  large  neurons  was  fur- 
ther confirmed by localization of NF-L protein using a poly- 
clonal antibody that recognizes NF-L in formalin-fixed tissue 
sections.  (The mAb used for earlier immunoblot and  im- 
munofluorescence analyses did not recognize NF-L in for- 
malin-fixed tissue.) As shown in Fig. 8 B, large neuronal cell 
bodies were intensely  stained,  with  little or no detectable 
NF-L in Schwann cells or smaller neurons.  While the anti- 
body cannot distinguish between the endogenous and trans- 
gene  NF-L,  these  results  clearly  demonstrate  that  if the 
transgene product is present at substantial levels, its accumu- 
lation must be restricted to these large neurons. 
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L  mRNAs  and  protein  in 
transgenic  sensory  neurons. 
(A)  In  situ  hybridization  of 
35S-labeled cDNA that specif- 
ically  hybridizes  with  NF-L 
mRNAs was performed on tis- 
sue  sections  containing lum- 
bar sensory neurons from an 
animal  expressing  the pMSV- 
NF-L transgene.  The autora- 
diogram was exposed for 5 d. 
Large arrows point to neuron 
cell  bodies  covered with  sil- 
ver grains.  Small arrows point 
to areas  enriched in Schwann 
cells.  (B) Immunohistochem- 
ical  localization  of NF-L  in 
transgenic  sensory  neurons. 
This formalin-fixed tissue was 
stained with a polyclonal anti- 
body to NF-L. Bars,  25 /~m. 
We next determined whether comparable increases in NF- 
L synthesis were detectable in these DRG neurons that con- 
tain elevated levels of NF-L mRNAs. To do this, we isolated 
L4 and L5 DRG of transgenic animals and nontransgenic lit- 
termate  controls.  These  were  incubated  with  psS]methio- 
nine for 15 rain to label newly synthesized proteins,  which 
were then separated by SDS-PAGE and analyzed by fluorog- 
raphy. The pattern of newly synthesized proteins was identi- 
cal in control and transgenic mice with the exception that in 
transgenic  animals  there  was a  clear  elevation  in  a  68-kD 
polypeptide, which is the expected size of NF-L (see Fig. 7 
B). This increase in the rate of synthesis of NF-L is compara- 
Monteiro et al. Expression  of NF-L in Transgenic Mice  1553 Figure 9. Increased NF density in transgenic axons.  Electron micrographs compare representative areas of axoplasm in large myelinated 
nerve fibers of (A) a control and (B) a transgenic animal expressing pMSV NF-L. NF density is greater and the orientation of NF is more 
variable in transgenic as compared to control axons.  Bars,  0.5/~m.  (C) Quantitation of NF density  in large myelinated nerve fibers of 
transgenic (light bars) and littermate control animals (dark bars).  NF density is ranked from greatest to least for each group in order to 
facilitate comparison. 
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Figure 10.  Comparison of mean axonal diameters in the sciatic 
nerves of control animals and transgenic animals expressing pMSV- 
NF-L. Axonal cross-sectional areas were measured using a com- 
puter-based system and mean diameters were calculated. Nerves 
were analyzed from two transgenic and two control animals; mean 
cross-sectional areas were measured for 2,525 control axons and 
2,975 transgenic axons. 
ble to the increase in NF-L RNAs,  although the relatively 
low level of NF-L in control DRG precluded precise quanti- 
tation. 
To test whether this increased rate of synthesis of NF-L in 
the neuron cell bodies resulted in increased levels of NF-L 
protein in axons, we analyzed the abundance of NF-L protein 
in the sciatic nerves of control and transgenic animals. Equal 
amounts of nerve extracts from two MSV-NF-L-58 trans- 
genic animals and from two age-matched, littermate controls 
were immunoblotted for NF-L. Fig. 7 C shows the Coomas- 
sie stain of total nerve proteins and Fig. 7 D displays the cor- 
responding NF-L immunoblot. Clearly, the transgenic sam- 
ples contain substantially more NF-L (three to six times as 
much by densitometry). We have performed this experiment 
three times with six transgenic animals and have always ob- 
served a similar increase in NF-L content. Additional immu- 
noblots of sciatic nerve proteins revealed that the levels of 
NF-M  and NF-H subunits  were comparable in transgenic 
and control animals (data not shown). It is highly likely that 
the  increased abundance of NF-L in the  sciatic nerves of 
transgenic animals reflects the axonal transport of increased 
amounts of NF-L in these nerve fibers (as opposed to stabili- 
zation of NF-L in transgenic nerves), although we have not 
yet directly tested this. 
Characterization of  Peripheral  Axons of Transgenic 
Mice by Electron Microscopy 
The  morphological  consequences  of increased  NF-L  ac- 
cumulation in the sciatic nerves of transgenic animals were 
analyzed  by  electron microscopy.  Sciatic  nerves  isolated 
from adult (>6-mo-old) transgenic animals and from control 
nontransgenic littermates were fixed in 5 % glutaraldehyde 
and embedded in Epon,  and transverse sections were ob- 
tained and analyzed by electron microscopy. Comparison of 
the number of neurofilaments within both large and small 
caliber myelinated axons revealed a clear increase in the den- 
sity of neurofilaments in the transgenic axons (compare Fig. 
9, A and B).  By carefully counting NF number,  we deter- 
mined the NF  density to be 40  ___  20 NF//~m 2 in control 
nerves and 88  +  25 NF//~m 2 in transgenic axons. The rela- 
tively large SDs in NF density are, at least in part, the conse- 
quence of the difficulty in accurately counting NF, particu- 
larly in the transgenic axons where NFs are not uniformly 
aligned parallel to the longitudinal  axis  (e.g.,  Fig.  9  B). 
Since we did not count these nonaligned NFs,  the actual 
differences in NF content between control and transgenic 
axons is actually greater. In any event, the measured 2.2-fold 
increased density of NF in transgenic axons was not accom- 
panied  by  a  detectable change  in  overall axonal  caliber. 
Cross-sectional areas were measured for 5,500 axons and a 
histogram of the frequency of axonal diameters (calculated 
from the areas) revealed no significant change in axonal size 
(Fig.  10). 
(It should be noted that sciatic nerve contains both sensory 
and motor axons, with the former arising from the DRG and 
the latter from the ventral spinal cord. The increase in NF 
density was seen in essentially all myelinated axons in the 
sciatic nerves of transgenic animals,  indicating that NF-L 
content was increased in both sensory and motor fibers.) 
Discussion 
A  series of preceding efforts had proposed a major role of 
NF gene expression in the control of axonal caliber.  The 
most compelling evidence demonstrated that reductions in 
NF gene expression after axotomy are associated with de- 
creased  axonal  caliber  in  large  myelinated  nerve  fibers 
(Hoffman et al., 1987). Additional evidence comes from re- 
cent studies demonstrating that the radial growth of myelin- 
ated nerve fibers, which occurs during postnatal develop- 
ment, coincides temporally with the induction of NF gene 
expression in developing sensory neurons. This induction is 
absent in neurons giving rise to unmyelinated fibers, which 
contain relatively few NFs and do not undergo significant 
radial growth (Muma,  N.  A.,  and P.  N.  Hoffman, unpub- 
lished  observations).  Although  the  exact mechanisms  by 
which NF content influences axonal caliber are unknown, 
these observations collectively support the hypothesis that 
NF gene expression is,  at the least,  a prerequisite for the 
radial growth of axons. 
Previous studies have demonstrated a close correlation be- 
tween axonal cross-sectional area and the axonal NF content 
of large myelinated nerve fibers  (Friede and  Samorajski, 
1970;  Weiss  and Mayr,  1971; Berthold,  1978).  Although 
modest differences in axonal NF density (,'025 %) have been 
reported among different populations of neurons (Price et 
al.,  1988)  and  in different regions of small-caliber nerve 
fibers (Nixon and Logvinenko, 1986; Parhad et al.,  1987), 
greater variations of NF density are not normally observed. 
The alterations  in axonal NF  content associated  with  so- 
matofugal axonal atrophy (where NF content decreases) and 
with normal postnatal development (where NF content in- 
creases)  correlate with  changes  in  axonal  cross-sectional 
area, rather than changes in NF density (Friede and Sam- 
orajski, 1970; Hoffman et al., 1984; Hoffman et al., 1985). 
Substantial increases in NF density are associated with the 
axonal abnormality induced by systemic intoxication with the 
neurotoxin iminodipropionitrile (Parhad et al., 1987), which 
selectively impairs NF transport (Griffin et al.,  1978)  and 
leads to a disorganization of axoplasm characterized by the 
malorientation of NF and the segregation of NF and microtu- 
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et al., 1983). Like the iminodipropionitrile example, overex- 
pression of wild-type NF-L yields not only an abnormal in- 
crease in NF density, but also disorganization of the axonal 
cytoskeleton. 
Since the additional NF in the axons of transgenic animals 
are constructed primarily from NF-L, our findings demon- 
strate that an increase in filaments assembled primarily from 
NF-L has little effect on axonal caliber. Of course, we cannot 
exclude the possibility that a greater increase in NF-L ac- 
cumulation would ultimately have resulted in altered axonal 
caliber, as happens in animals intoxicated with iminodipro- 
pionitrile.  However, since NFs are normally composed of 
three different subunits, a simpler view is that an increase in 
NF-L alone may not result in the formation of filaments with 
the same properties as those composed of normal ratios of 
the three subunits. 
Indeed, although NF-L can form filaments in the absence 
of the other subunits (Geisler and Weber,  1981; Liem and 
Hutchinson, 1982), it does not carry the extended carboxy- 
terminal tail shared by NF-M and NF-H (Sharp et al.,  1982; 
Hirokawa  et  al.,  1984;  Hisanaga  and  Hirokawa,  1988), 
which  in  the case of NF-H appears  to be associated  NF 
cross-bridges (Hirokawa et al.,  1984;  Hisanaga and Hiro- 
kawa,  1988).  It is possible that these cross-bridges play a 
critical role in the regulation of axonal caliber. In fact, the 
carboxy-terminal tail of NF-H  is  highly enriched in both 
charged  amino  acids  and  potential  phosphorylation sites 
(Lees et al.,  1988), suggesting that these cross-bridges may 
repel adjacent NF, thereby reducing NF density. The possi- 
ble role of NF cross-bridges in the control of axonal caliber 
can  now  be  explored by producing  additional  transgenic 
mice expressing higher levels of NF-M and NF-H subunits. 
Two  other  transgenic  founder  mice  obtained  with  the 
authentic NF-L gene promoter (pNF-L[Bam]) showed ac- 
cumulation of NF-L RNAs restricted to tissue enriched in 
neurons (e.g., brain), similar to the endogenous NF-L gene. 
This  indicates  that  most,  if not all,  of the  elements that 
specify neuronal-specific expression must be contained with- 
in the 7-kb transgene fragment. Although we have not shown 
it directly, we assume that expression of the pNF-L(Bam) 
transgene is restricted to neurons based on the work of  Julien 
et al. (1987) who demonstrated by in situ hybridization that 
expression of a human NF-L transgene contained on a 21.5- 
kb genomic DNA fragment was localized to neurons. Fur- 
ther, Byrne and Ruddle (1989) had previously demonstrated 
that the 1.5-kb segment of the mouse NF-L gene just 5' to 
transcription initiation was sufficient to yield brain-specific 
expression of a marker gene, but they could not determine 
the level of expression. Using the same presumptive NF-L 
promoter domain, we find transgene RNAs at a level 20% 
of the endogenous NF-L mRNAs in brain. Since NF-L RNA 
is moderately abundant, this indicates that use of the NF-L 
controlling sequences should produce a relatively high level 
of transgene expression targeted to most (and perhaps all) 
neurons. 
MSV LTR-promoted transgenes produced very high ex- 
pression of NF-L in various tissues, including many where 
NFs  are  not normally expressed.  Somewhat surprisingly, 
NF-L accumulated to as much as 2-3 % of total cell protein 
in tissues like kidney and skeletal muscle, and 0.5% in heart, 
and yet it had no catastrophic effect on the function of these 
tissues nor did it affect mouse development or survival. (The 
founder mice are now 2 yr old.) This may at first seem sur- 
prising since NF-L is normally expressed only in postmitotic 
neurons. The combination of its unique expression in neu- 
rons and its extreme insolubility initially suggested that inap- 
propriate expression of NF-L might be detrimental to contin- 
uing mitosis. However, using DNA transfection of cultured 
cells we showed that NF-L could accumulate to be the most 
abundant  cellular  protein  without  affecting  cell  growth 
(Monteiro and Cleveland, 1989). Our current results extend 
this finding to a true in vivo situation: inappropriate expres- 
sion of NF-L did not affect the viability of the many different 
mitotic cell types in these transgenic mice. Furthermore, we 
have observed massive accumulation of NF-L filaments in 
kidney of transgenic mice without any obvious effect on lon- 
gevity. The only phenotypic effect we have observed upon 
nontissue-specific expression of NF-L is the formation of 
cataracts. Capetanaki et al. (1989) also observed cataracts in 
transgenic mice that expressed the chicken vimentin gene in 
lens  and  concluded that  vimentin  expression specifically 
prevented normal lens cell differentiation, ultimately result- 
ing in cataract formation.  An alternative explanation that 
may in fact explain both that observation and ours is that the 
lens has a very restricted tolerance for expression of "for- 
eign" proteins without the phenotypic consequence of cata- 
ract formation. 
One set of previous transgenic animals had demonstrated 
that MSV directed transgene expression at high levels in lens 
and testis, with lower levels in brain and kidney (Khillan et 
al., 1987). Our findings confirm that the MSV promoter can 
be used to yield extraordinarily high levels of transgene ex- 
pression albeit in a different set of tissues than seen earlier. 
Specifically, we have now documented MSV-directed expres- 
sion in tissues rich in neurons. Although lower than that seen 
in the highest expressing tissues,  transgene expression in 
DRG and in brain was nevertheless substantial enough that 
MSV-NF-L RNAs were 5-20-fold higher than those from the 
endogenous NF-L genes.  Since a  similar pattern was  ob- 
served in three different transgenic lines, this suggests that 
the MSV LTR may also be of general use to force high level 
expression of selected gene products within neurons. 
An  unexpected finding  was  that  the  increase  of MSV- 
promoted NF-L RNAs in the brains of transgenic mice did 
not result in a similar increase in NF-L protein. This clearly 
indicates  the  presence  of posttranscriptional  mechanisms 
that maintain the level of NF-L protein in brain.  With the 
current mice we can not easily pursue the actual mechanism 
involved since the transgene translation product is identical 
to the endogenous NF-L. But in any event, the present data 
suggest interesting and novel posttranscriptional regulation 
of NF-L in the central nervous system. 
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